We demonstrated that THC, one of the active anticancer forms of CUR in vivo, markedly inhibited tumor angiogenesis in CaSki-implanted female nude mice models by downregulation of HIF-1-α, VEGF/VEGFR-2 pathway. The gene discussed is VEGFA; the disease is neoplasm.